Adoptive Cell Transfer Congress is organized by Global Engage Ltd and will be held from Oct 10 - 11, 2019 at London, England, United Kingdom.
Examining the Latest Advances in CAR and TCR Therapies
Part of the Research & Technology Series, this conference explores the exciting field of cell and gene therapy in immuno-oncology.
The modification of patient and donor t cells offers a potent weapon in the fight against cancer, and with the recent regulatory approval, several CAR-T Cell products in the US and Europe these therapies stand poised to enter the clinic.
This conference offers experts working in the pharmaceutical industry and academia the opportunity to explore the latest developments in CAR T cell therapies, and the up-and-coming field of T Cell Receptor therapies. Presentations will explore design and development strategies for the modification of patient and donor t cells, receptor engineering and target selection, and will review the advantages and challenges remaining in their use.
The Adoptive Cell Transfer Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.
Additional details will be posted as soon as they are available.
|Contact No. :||0)1865 849841
+44 (0) 1865 379865
|Registration Type||End Date||Price|
|Industry Fee||09 Oct,2019||GBP 999.00|
|Academic/NFP Fee||09 Oct,2019||GBP 499.00|
|Solution Provider Fee||09 Oct,2019||GBP 1499.00|